Earnings Releases·Nov 5, 2026, 7:05 AM ET

GPGI — Third Quarter 2026 Earnings Summary

Full-year 2026 Pro Forma Adjusted EBITDA guidance was lowered to $520–$550 million (midpoint ~$535 million), a decrease of approximately 8% from the prior midpoint, while Net Sales guidance remains unchanged at $2,034–$2,064 million.
Third-quarter results showed Pro Forma Adjusted Net Sales of $509.6 million (+0.5% YoY) and Pro Forma Adjusted EBITDA of $146.3 million (+6.6% YoY), driven by record performance at CompoSecure which offset a 0.9% EBITDA decline at Husky due to cost execution delays.
The company anticipates a return to its long-term growth algorithm in 2027, targeting mid-to-high single-digit organic revenue growth, 100+ basis points of margin expansion, and double-digit EBITDA growth, with Husky expected to grow flat to low single digits in Q4.
Balance sheet strength remains robust with $176 million in cash, $569 million in total liquidity, and a Net Debt to LTM EBITDA ratio of 3.7x, alongside a strategic focus on debt paydown and disciplined capital allocation.